Literature DB >> 18337702

Isolation of quinupristin/dalfopristin-resistant Streptococcus agalactiae from asymptomatic Korean women.

Hye Ran Nam1, Hak Mee Lee, Yeonhee Lee.   

Abstract

Seven Streptococcus agalactiae isolates were obtained from the vagina of 80 asymptomatic women. Three of these isolates showed multi-drug resistant (MDR) phenotypes: two isolates were resistant to clarithromycin, clindamycin, erythromycin, and tetracycline; and one isolate was resistant to clarithromycin, clindamycin, erythromycin, tetracycline, and quinupristin/dalfopristin. There was no clonal relationship among the MDR isolates. This is the first report of quinupristin/dalfopristin-resistant S. agalactiae.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18337702     DOI： 10.1007/s12275-007-0217-1

Source DB:  PubMed          Journal:  J Microbiol        ISSN： 1225-8873            Impact factor:   3.422


  17 in total

1.  In-vitro activity of RP 59500, a semisynthetic streptogramin, against staphylococci and streptococci.

Authors:  J C Pechère
Journal:  J Antimicrob Chemother       Date:  1992-07       Impact factor: 5.790

Review 2.  Emerging role of lactobacilli in the control and maintenance of the vaginal bacterial microflora.

Authors:  V Redondo-Lopez; R L Cook; J D Sobel
Journal:  Rev Infect Dis       Date:  1990 Sep-Oct

3.  Invasive group B streptococcal disease in Maryland nursing home residents.

Authors:  K J Henning; E L Hall; D M Dwyer; L Billmann; A Schuchat; J A Johnson; L H Harrison
Journal:  J Infect Dis       Date:  2001-03-01       Impact factor: 5.226

4.  Bias caused by template annealing in the amplification of mixtures of 16S rRNA genes by PCR.

Authors:  M T Suzuki; S J Giovannoni
Journal:  Appl Environ Microbiol       Date:  1996-02       Impact factor: 4.792

5.  Macrolide and tetracycline resistance and molecular relationships of clinical strains of Streptococcus agalactiae.

Authors:  Esther Culebras; Iciar Rodriguez-Avial; Carmen Betriu; Montserrat Redondo; Juan J Picazo
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

6.  A new phenotype of resistance to lincosamide and streptogramin A-type antibiotics in Streptococcus agalactiae in New Zealand.

Authors:  Brigitte Malbruny; Anja M Werno; Trevor P Anderson; David R Murdoch; Roland Leclercq
Journal:  J Antimicrob Chemother       Date:  2004-11-10       Impact factor: 5.790

7.  In vitro activity of quinupristin/dalfopristin against selected bacterial pathogens isolated in Italy.

Authors:  Anna Marchese; Eugenio A. Debbia; Gian Carlo Schito
Journal:  Clin Microbiol Infect       Date:  1999-08       Impact factor: 8.067

8.  High incidence of erythromycin-resistant streptococci in Taiwan.

Authors:  J J Wu; K Y Lin; P R Hsueh; J W Liu; H I Pan; S M Sheu
Journal:  Antimicrob Agents Chemother       Date:  1997-04       Impact factor: 5.191

9.  Antimicrobial susceptibilities of group B streptococci isolated from patients with invasive disease: 10-year perspective.

Authors:  D R Murdoch; L B Reller
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

10.  Genome sequence of Streptococcus agalactiae, a pathogen causing invasive neonatal disease.

Authors:  Philippe Glaser; Christophe Rusniok; Carmen Buchrieser; Fabien Chevalier; Lionel Frangeul; Tarek Msadek; Mohamed Zouine; Elisabeth Couvé; Lila Lalioui; Claire Poyart; Patrick Trieu-Cuot; Frank Kunst
Journal:  Mol Microbiol       Date:  2002-09       Impact factor: 3.501
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.